Celebrity Inventors
Actor Zeppo Marx patented a "Cardiac Pulse Rate Monitor" in 1969.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6528497 | Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same Novel synthetic polysaccharides for use in the treatment of pathologies associated with a coagulation dysfunction.... | 03/04/2003 |
| 6528491 | Pyranoside derivatives The present invention relates to new pyranoside derivatives of general formula I, processes for preparing them as well as their use as medicaments: ##STR1##... | 03/04/2003 |
| 6528490 | Oenothein medicaments The invention provides medicaments comprising an oenothein, including topical formulations for use as free radical scavengers, or to treat irritation, or to treat inflammation. The oenothein for use in such formulations, such as oenothein-A or oenothein-B... | 03/04/2003 |
| 6525145 | Polylactide/dextran graft co-polymers for biomaterial and tissue engineering applications A biocompatible, biodegradable, copolymer is prepared from cross-linking a polylactic acid with a polysaccharide such as dextran. The resulting copolymer is a biodegradable hydrogel or solid having both hydrophobic and hydrophilic properties and provides ... | 02/25/2003 |
| 6525028 | Immunoeffector compounds This invention provides compounds containing a 2-deoxy-2-amino-ଲ-D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group. The invention further provides methods for inducing an immune response using the compounds ... | 02/25/2003 |
| 6518248 | Method of treating gastric or colon cancer by administration of a sulfoquinovosylacylglycerol ester An anticancer drug includes a compound represented by Formula (1): ##STR1## where R101 represents an acyl moiety of a saturated higher fatty acid, and R102 represents a hydrogen atom or an acyl moiety of a saturated higher fatty acid... | 02/11/2003 |
| 6518410 | Sulfoquinovosylacylglycerol derivative, and use thereof as medicaments A method for immunosuppression in a subject comprising administering to the subject in need thereof, a pharmaceutically effective amount of at least one sulfoquinovosylacylglycerol derivative represented by General formula (1-1): ##STR1## wherein R | 02/11/2003 |
| 6518302 | Remedies ##STR1## Compounds represented by general formula (I) wherein X represents OH or OSO3 H; and R represents a substituent other than OH which allows, after leaving, the induction of unsaturated bonds into the 3- and 4-positions of 3,6-anhydrogala... | 02/11/2003 |
| 6517678 | Modified polysaccharides containing amphiphillic hydrocarbon moieties Modified polysaccharides (such as starches, gums, chitosans, celluloses, alginates, sugars, etc.), which are commonly used in the paper industry as strengthening agents, surface sizes, coating binders, emulsifiers and adhesives, can be combined into a sin... | 02/11/2003 |
| 6512099 | Roselipin derivative Roselipin derivatives which are represented by the following formula: ##STR1## [wherein R1 represents a hydrogen atom, mannose or acetylated mannose, R2 represents a hydrogen atom or a methyl group, and R3 represents a met... | 01/28/2003 |
| 6511965 | Ether type lipid A 1-carboxylic acid analogs A compound of formula (I) below, which exhibits excellent macrophage activity inhibitory action, is useful for the treatment or prophylaxis of inflammatory disorders, autoimmune diseases or septicemia. In a preferred embodiment, R1 and R3 | 01/28/2003 |
| 6504018 | Process for preparing pale-colored and transparent alkyl glycosides A process for preparing pale-colored and transparent alkyl glycosides by reacting glucose and high fatty alcohol in presence of an acid catalyst is disclosed. The process comprises the steps of admixing, reacting, neutralizing, distilling, diluting and bl... | 01/07/2003 |
| 6503885 | Carboxymethylgalactose derivatives Carboxymethylgalactose derivatives represented by general formula (1); ##STR1## and salts thereof, which exhibit reactivity to selectins and are useful as inhibitors against selectin-related diseases such as various inflammations and cancerous metastasis;... | 01/07/2003 |
| 6500936 | Pluraflavins and derivatives thereof, process for their preparation and use thereof The invention relates to a compound of formula (I) ##STR1## wherein R1 is a sugar; R2 is --CH2 --O--(R7)m, R7 representing a sugar, or is --COOH; R3 is an epoxide-comprising group, or is C | 12/31/2002 |
| 6498246 | Glycosaminoglycan derivatives and processes for preparing same The invention provides novel glycosaminoglycan derivatives having a repeating unit structure of two saccharides of hexosamine and hexuronic acid as a backbone structure, in which the bonds between 2- and 3-positions carbon atoms of hexuronic acid as its c... | 12/24/2002 |
| 6495678 | Immunosuppressant containing glucopyranose derivative as active ingredient An immunosuppressant comprising Glucopyranose derivatives of the formula (I): ##STR1## wherein R is H, OH etc; G is --CH2 CH(R1 --R2)(R3 --R4), in which R1 is a single bond, OCO-alkyl; R | 12/17/2002 |
| 6495528 | 2-(Purin -9-yl)-tetrahydrofuran-3,4-diol derivatives A series of 2-(Purin-9-yl)-tetrahydrofuran-3,4-diol derivatives with broad anti-inflammatory properties which inhibit leukocyte recruitment and activation and which are agonists of the adenosine 2a receptor are described.... | 12/17/2002 |
| 6492339 | Compositions comprising D-chiro inositol and sulfonylureas and methods of treatment thereof The present invention provides compositions comprising synergistically effective amounts of D-chiro-inositol and sulfonylureas. The present invention also provides methods to treat a subject with insulin resistance comprising administration of D-chiro-ino... | 12/10/2002 |
| 6492350 | Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain A new method is presented which is useful in the prevention of the common cold (also called non-allergic rhinitis, viral upper respiratory tract infection, viral URI, etc and for this presentation will be referred to as the "common cold") in mammals, incl... | 12/10/2002 |
| 6492341 | Preparation of fagopyritols and uses therefor The present invention describes isolated Fagopyritol A1, isolated Fagopyritol A3, and isolated Fagopyritol B3. Compositions which include two or more of Fagopyritol A1, Fagopyritol A2, Fagopyritol A3, Fagopyritol B1, Fagopyritol B2, Fagopyritol B3, and D-... | 12/10/2002 |
| 6489469 | Method for storing or transporting erythritol solution A method for the storage or transportation of an erythritol by maintaining erythritol in the form of a solution at a concentration and at a temperature in given ranges. Setting up such conditions enables long-term storage of an erythritol solution or tran... | 12/03/2002 |
| 6489310 | Fiber blend for enteral composition An enteral composition which contains a protein source, a lipid source, a carbohydrate source, and a fibre blend. The fibre blend contains inulin and fructo-oligosaccharides and has 45 to 55% by weight of the blend of soluble fibre and 45 to 55% by weight... | 12/03/2002 |
| 6489301 | Solid pharmaceutical preparation for dialysis and a process for producing the same There is provided a solid pharmaceutical preparation for dialysis consisting of one composition, which is excellent in uniformity of the ingredients contained therein, is capable of preventing not only a reaction between sodium bicarbonate and a solid org... | 12/03/2002 |
| 6488946 | Stable water-in-oil emulsions containing an emulsifier on oleyl-and/or isostearyl-glycoside The present invention relates to novel stable emulsions containing 5 to 70% by weight of an aqueous phase 20 to 90% by weight of a fatty phase; and 3 to 25% by weight of an emulsifier comprising 10 to 90% by weight, preferably 10 to 50% by weight a... | 12/03/2002 |
| 6486127 | Compositions comprising D-chiro inositol and lipid lowering compounds and methods of treatment thereof The present invention relates to methods of reducing serum lipids in insulin resistant subjects comprising administration of synergistically effective amounts of D-chiro-inositol and lipid lowering medications. The present invention provides methods to tr... | 11/26/2002 |
| 6479461 | Use of alkylmonoglucosides as molecular vectors The invention concerns the use as molecular vector in pharnaceutical, cosmetic and food products of alkylmonoglucosides of general formula (I) in which R1 is a linear or branched C2 -C18 alkyl radical.... | 11/12/2002 |
| 6479054 | Process for obtaining genistin-rich isoflavone composition A process for simply and efficiently obtaining an isoflavone composition having a high ratio of genistin, which useful as a food material and the like, wherein in the process for obtaining genistin from a isoflavone inclusion, genistin is selectively prec... | 11/12/2002 |
| 6479650 | Fluorescent nucleoside analogs and combinatorial fluorophore arrays comprising same The present invention provides fluorescent nucleoside analogs which comprise a fluorescent cyclic compound joined to a carbon of a sugar molecule such as pentose, hexose, ribose or deoxyribose or analogs thereof in either an or ଲ configurati... | 11/12/2002 |
| 6475992 | Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria The invention provides a method of potentiating the activity of antibacterial agents that act on bacterial cell walls, comprising the step of administering to a subject an antibacterial agent and an aminoglycoside to attain a peak concentration of at leas... | 11/05/2002 |
| 6475991 | Use of -alkylglucosides and -alkylglucoside esters as anti-microbial an agents The present invention embraces methods and compositions which employ antimicrobial compositions which are -alkylglucosides and esters thereof.... | 11/05/2002 |
| 6464993 | Use of a composition bases on isostearyl glycoside and isostearyl alcohol as an agent that improves the resistance of a cosmetic composition to water The present invention relates to the use of a composition comprising: 10 to 90% by weight, preferably 10 to 50% by weight and particularly preferably 10 to 40% by weight of an isostearyl glycoside with a degree of polymerization of between 1 and 3; and 90 to 1... | 10/15/2002 |
| 6462191 | Synthesis of 2-deoxy-2-fluoro-arabinose derivatives A process for deoxofluorinating a C2 -hydroxyl group of a furanose, includes: (a) mixing the furanose and a deoxofluorinating agent in a solvent to form a reaction mixture, and (b) heating the reaction mixture to greater than about 50° C. The ... | 10/08/2002 |
| 6455512 | Water-soluble esterified hydrocolloids Emulsifiers based on the reaction product of hydrocolloid and dicarboxylic anhydrides, especially useful in the preparation of oil-in-water emulsions.... | 09/24/2002 |
| 6455507 | Benzimidazole derivatives Benzimidazole derivatives useful for treating or preventing viral infections such as those caused by herpes viruses or in the treatment of restenosis following surgical techniques. Methods of preparing these benzimidazole derivatives and pharmaceutical co... | 09/24/2002 |
| 6451357 | Method for purification of aloesin The present invention relates generally to a method for the purification of aloesin, a C-glucosylated 5-methylchromone, tyrosinase inhibitor isolated from Aloe. Specifically, the present invention relates to a method for the crystallization of aloesin, th... | 09/17/2002 |
| 6444795 | 1-0-(2-propenyl)-6-0-sulfonylpyranosides 1-O-(2-propenyl)-6-O-sulfonylpyranoside represented by the formula ##STR1## wherein R1, R2 and R3 each independently represents an alkyl or substituted silyl group, and R4 represents an alkylsulfonyl or arylsulf... | 09/03/2002 |
| 6444655 | Galactopyranosides and their use The present invention relates to simplified synthesis, new carbohydrate-based products and practical use of different carbohydrate-based products. Examples of these are (Gal댑-3Gal), GlcNAc댡-3Gal, - or ଲ-glycosides thereof, ... | 09/03/2002 |
| 6432682 | Substances KF-1040 and process for producing of the same A process for producing a substance KF-1040A represented by formula (I), and another substance KF-1040B represented by formula (II), which comprises culturing microorganisms capable of producing the substances KF-1040A and KF-1040B, thus accumulating thes... | 08/13/2002 |
| 6426421 | Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries One aspect of the present invention relates to optionally substituted halogenated benzyl halides and the like. These compounds are useful as halogenated benzyl ether-based protecting groups for a variety of functional groups. Another aspect of the present... | 07/30/2002 |
| 6417339 | Dendrimers based on saccharides The invention relates to dendrimers comprising an initiator core with at least two functional groups and at least two saccharides, a process for preparing sch dendrimers as well as uses thereof.... | 07/09/2002 |
